Cancer Research UK and University College London Cancer Trials Centre
London, England, United Kingdom
About Cancer Research UK and University College London Cancer Trials Centre
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Cancer Research UK
2
University College, London
2
EBMT Solid Tumors Working Party
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Karus Therapeutics Limited
1
University College London (UCL) Cancer Institute
1
University of Glasgow
1
Clinical Trials at Cancer Research UK and University College London Cancer Trials Centre
During the past decade, Cancer Research UK and University College London Cancer Trials Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery
Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer
Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
2010-06-01
2012-12-01
Completed
130
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Cancer Research UK" with 2 trials
sponsored, "University College, London" with 2 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research UK and University College London Cancer Trials Centre"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Cancer Research UK and University College London Cancer Trials Centre
According to Clinical.Site data, the most researched conditions in "Cancer Research UK and University College London Cancer Trials Centre" are
"Lymphoma" (2 trials), "Metastatic Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Advanced Ovarian Cancer" (1 trials) and "Anal Cancer" (1 trials). Many other conditions were trialed in "Cancer Research UK and University College London Cancer Trials Centre" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Research UK and University College London Cancer Trials Centre
Most popular intervention types in "Cancer Research UK and University College London Cancer Trials Centre" are "Drug" (10 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "carboplatin" (2 trials), "cyclophosphamide" (2 trials), "fluorouracil" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Research UK and University College London Cancer Trials Centre
The vast majority of trials in "Cancer Research UK and University College London Cancer Trials Centre" are
7 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at Cancer Research UK and University College London Cancer Trials Centre
Currently, there are NaN active trials in "Cancer Research UK and University College London Cancer Trials Centre".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Cancer Research UK and University College London Cancer Trials Centre,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Research UK and University College London Cancer Trials Centre, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".